This page in English
Laddar profil information

Om mig

Docent i experimentell onkologi. Kliniskt verksam som läkare inom onkologi.

I mitt arbete kombinerar jag patientverksamhet på en onkologisk universitetsklinik (Akademiska sjukhuset) med patientnära cancerforskning, doktorandhandledning och undervisning av läkarstudenter. 

Medlem av styrgruppen för den Nationella Forskarskolan för Klinisk Cancerforskning (NatiOn), Svenska Njurcancergruppen, och Svenska Palliativregistrets Forskargrupp.  

 

Forskningsbeskrivning

Fokus ligger på (1) anti-angiogena och anti-inflammatoriska substansers användbarhet i behandlingen av svårt sjuka cancerpatienter, främst njurcancer och lungcancer; (2) Symtomkontroll hos cancerpatienter i livets slutskede.

Publikationer

Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma
Stenman M, Laurell A, Lindskog M
Medical oncology (Northwood, London, England) 2014;31(3):841-

Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion
Al Hashmi S, Sadeghi B, Hassan Z, Abedi-valugerdi M, Lindskog M, Hassan M
Bone marrow transplantation 2013;48(6):843-8

Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
Swedish Lung Canc Study Grp, Sorenson S, Fohlin H, Lindgren A, Lindskog M, Bergman B, et al
EUROPEAN JOURNAL OF CANCER 2013;49(1):115-20

Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo
Gleissman H, Segerström L, Hamberg M, Ponthan F, Lindskog M, Johnsen Ji, et al
International journal of cancer 2011;128(7):1703-11

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates
Gleissman H, Yang R, Martinod K, Lindskog M, Serhan Cn, Johnsen Ji, et al
FASEB JOURNAL 2010;24(3):906-15

Fish oil delays lymphoma progression in the TLL mouse
Johansson As, Norén-nyström U, Larefalk A, Holmberg D, Lindskog M
Leukemia & lymphoma 2010;51(11):2092-7

Cytotoxic Effects of Cardiac Glycosides in Colon Cancer Cells, Alone and in Combination with Standard Chemotherapeutic Drugs
Felth J, Rickardson L, Rosen J, Wickstrom M, Fryknas M, Lindskog M, et al
JOURNAL OF NATURAL PRODUCTS 2009;72(11):1969-74

Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide
Johansson As, Pawelzik Sc, Larefalk A, Jakobsson Pj, Holmberg D, Lindskog M
LEUKEMIA & LYMPHOMA 2009;50(7):1198-203

Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo
Paimberg E, Johnsen Ji, Paulsson J, Gleissman H, Wickstrom M, Edgren M, et al
INTERNATIONAL JOURNAL OF CANCER 2009;124(5):1227-34

OMEGA-3 FATTY ACIDS IN CHILDHOOD CANCER: ELUCIDATION OF THE DOCOSAHEXAENOIC ACID METABOLIC PATHWAY IN NEUROBLASTOMA AND DEFINITION OF CYTOTOXIC INTERMEDIATES
Kogner P, Gleissman H, Serhan Cn, Hamberg M, Segerstrom L, Lindskog M, et al
PEDIATRIC BLOOD & CANCER 2009;53(5):807-807

THE EFFECT OF OMEGA-3 AS A DIETARY SUPPLEMENT IN A MOUSE MODEL OF STEM CELL TRANSPLANTATION (SCT)
Al-hashmi A, Sadeghi B, Hassan Z, Lindskog M, Hassan M
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2009;:472-472

The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo
Wickstrom M, Johnsen Ji, Ponthan F, Segerstrom L, Sveinbjornsson B, Lindskog M, et al
MOLECULAR CANCER THERAPEUTICS 2007;6(9):2409-17

Neuroblastoma cell death in response to docosahexaenoic acid: Sensitization to chemotherapy and arsenic-induced oxidative stress
Lindskog M, Gleissman H, Ponthan F, Castro J, Kogner P, Johnsen Ji
INTERNATIONAL JOURNAL OF CANCER 2006;118(10):2584-93

NSAIDs in neuroblastoma therapy
Johnsen Ji, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, et al
CANCER LETTERS 2005;228(1-2):195-201

Proton magnetic resonance spectroscopy in neuroblastoma: Current status, prospects and limitations
Lindskog M, Spenger C, Klason T, Jarvet J, Graslund A, Johnsen Ji, et al
CANCER LETTERS 2005;228(1-2):247-55

Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo
Johnsen Ji, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, et al
CANCER RESEARCH 2004;64(20):7210-5

Monitoring intracellular metabolites in neuroblastoma with 1H NMR spectroscopy: effects of growth factor withdrawal and modulation of lipid metabolism
Lindskog M, Jarvet J, Graslund A, Kogner P
SPECTROSCOPY-AN INTERNATIONAL JOURNAL 2004;18(2):123-132

Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma
Lindskog M, Spenger C, Jarvet J, Graslund A, Kogner P
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2004;96(19):1457-66

Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts
Ponthan F, Lindskog M, Karnehed N, Castro J, Kogner P
ONCOLOGY REPORTS 2003;10(5):1587-92

Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (H-1 MRS)
Lindskog M, Kogner P, Ponthan F, Schweinhardt P, Sandstedt B, Heiden T, et al
BRITISH JOURNAL OF CANCER 2003;88(3):478-85

Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastorna cells in blood and bone marrow
Trager C, Kogner P, Lindskog M, Ponthan F, Kullman A, Kagedal B
CLINICAL CHEMISTRY 2003;49(1):104-12

Visa alla publikationer